Analyst Coverage
Oryzon Genomics, S.A. is currently followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Oryzon Genomics, S.A.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Oryzon Genomics, S.A. or its management. Oryzon Genomics, S.A. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
Publicy available reports
-
Edison Group (UK)AnalystSoo RomanovAdam McCarter4 April 202322 March 202321 February 202316 December 202216 September 202226 July 20229 June 202214 February 202211 December 202028 September 20201 January 20201 October 20191 April 20191 November 20181 July 20181 December 20171 May 20171 March 20171 December 20161 November 20161 March 2016
-
Estrategias de Inversión (ES)AnalystMaría Mira12 January 202330 October 20201 November 20191 September 20191 February 2019
-
Invest Securities (FR)AnalystJamila El BougriniThibaut Voglimacci - Stephanopoli21 September 202210 June 202217 November 202122 September 20217 December 202028 October 20201 December 20191 October 20191 September 20191 May 20191 November 2018
-
Ladenburg Thalmann (US)AnalystAhu Demir24 February 202320 September 202226 July 202213 June 202223 March 20229 February 2022
-
Luis Navia (ES)AnalystLuis Navia8 March 20238 November 202231 July 202225 February 20224 November 20215 August 20215 March 20215 November 202031 July 20201 March 20201 November 20191 February 20191 November 20181 September 20181 November 20171 September 20171 November 20161 September 2016
-
ROTH Capital Partners (US)AnalystJonathan Aschoff10 May 20234 April 202322 March 202328 February 202313 December 20223 November 202222 September 202227 July 202210 June 202219 April 202224 January 202214 December 202116 November 202112 July 202114 June 202110 May 20219 March 202123 February 20217 December 202017 September 20208 July 20201 April 20201 February 20201 July 20191 March 20191 June 20191 September 20181 May 20181 April 2018
Reports only available to clients and partners of the analyst company
-
Jefferies (US)
AnalystLucy Codrington et al -
Van Lanschot Kempen (NL)
AnalystSuzanne van Voorthuizen et al -
Rx Securities (UK)
AnalystJoseph Hedden
